Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis.

D Laszlo; C Rabascio; G Andreola; G Pruneri; V Raia; L Calabrese; D Radice; L Saronni; G Martinelli

doi:10.1080/10428190601078134

Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis.

Identifier:nobleid.org/w1/20260515/0DF9BDC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0DF9BDC1.svg?ark=w1%2F20260515%2F0DF9BDC1)](https://nobleid.org/work/w1/20260515/0DF9BDC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Chlorambucil - rituximab as first line combination therapy in follicular non-Hodgkin's lymphoma: a clinical and biological analysis.

Identifier:nobleid.org/w1/20260515/0DF9BDC1

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/0DF9BDC1.svg?ark=w1%2F20260515%2F0DF9BDC1)](https://nobleid.org/work/w1/20260515/0DF9BDC1)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work